JPRN-UMIN000046556已完成未知
Optimal individual administration of linezolid and tedizolid using saliva concentrations to avoid blood sampling A single oral and intravenous dose of linezolid and tedizolid in healthy adult males (investigator-initiated clinical study) - Optimal individual administration of linezolid and tedizolid using saliva concentrations to avoid blood sampling A single oral and intravenous dose of linezolid and tedizolid in healthy adult males (investigator-initiated clinical study)
niversity of Toyama0 个研究点目标入组 12 人开始时间: 2022年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) History of drug allergy 2) Hypersensitivity to the investigational drug 3) Participated in other clinical trials within the previous 2 weeks 4) Received drugs or supplements within the previous 3 days 5) Whole blood donor of 200 mL within the previous one month, blood component (platelets and plasma) donor within the previous 2 weeks, or Whole blood donor of 300 mL within the previous 3 months 6) 7) With childbearing potential and rejecting contraceptive methods during 1 week from the initial administration of the investigational drug 8) With abnormal findings on the medical examination within six months 9) Salivary gland disorder or oral disease 10) Liver or renal disease 11) Deemed inappropriate (for miscellaneous reasons) based on the assessment of either the principal investigator or the sub-investigator
研究者
相似试验
进行中（未招募）
不适用
Investigation of the blood levels of selected antibiotics in critically ill patients undergoing dialysisSepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and may result in either underdosing, causing treatment failure and antibiotic resistance, or overdosing resulting in drug toxicity. The aim of this study is to collect pharmacokinetic data for evaluating underdosing or overdosing of linezolid and meropenem in patients receiving renal replacement therapy.EUCTR2013-000899-16-DEDepartment of Pharmacy Unversitätsmedizin Mainz
进行中（未招募）
不适用
Target site pharmacokinetics of linezolid or tigecycline in patients with severe skin and skin structure infections (SSSI) associated with chronic fistulas. - Fistula-SD-MDEUCTR2011-000064-10-ATMed. Univ. Wien, Klinik für klinische Pharmakologie20
已完成
1 期
Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)Multi-Drug Resistant TuberculosisExtensively Drug Resistant TuberculosisNCT00691392Centers for Disease Control and Prevention26
进行中（未招募）
1 期
Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infectioThe study population will consist of a representative group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot complicated by osteomyelitis. Patients must be subjected to undergo surgical debridement and intravenous antimicrobial therapy.EUCTR2008-006153-41-ATMedical university Graz, Department of Plastic Surgery
进行中（未招募）
不适用
Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infectiodiabetic patients with soft tissue infection, necessiting antibiotic therapyEUCTR2007-007958-54-ATDepartment of Clinical Pharmacology, Medical University of Vienna